gotoper Sign Up Information

November 5-7, 2020
Emory Conference Center Hotel | Atlanta, GA

An increasing number of oncologists are focusing their clinical practices on the treatment of breast cancer, creating a need for specialized education. The School of Breast Oncology®, which has been held annually since 2003, was developed to advance patient care by providing a curriculum-based program focused exclusively on breast cancer clinical management. This intensive 3-day interactive program will provide a comprehensive review of data on the most important aspects of breast cancer biology, diagnostics, prevention, and treatment, with lectures emphasizing clinical implications presented by leading clinical investigators.

Register by April 1st and save 25%* using code SOBO20ESD

Benefits of Attending:

• Participate in dynamic case management discussions
• Discuss the future of breast oncology with Joyce O'Shaughnessy, MD
• Network with hundreds of healthcare professionals interested in breast oncology
• Improve your multidisciplinary care using the latest updates and strategies in breast oncology
• Learn from more than 25 expert faculty leading didactic presentations, panel discussions, and more

Accreditation/Credit Designation
Physicians' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians' Education Resource®, LLC, designates this live activity for AMA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians' Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669.

Saturday, March 21, 2020
MGM National Harbor® | Oxon Hill, MD

Use code SOGO20SD at checkout by to save 35%

Led by world-renowned experts John L. Marshall, MD, and Michael A. Choti, MD, MBA, FACS, this multitrack symposium, now in its fifth year, will provide attendees with the tools needed to personalize care for each one of their patients with gastrointestinal (GI) cancer. The program will include various modules that feature general presentations on important concepts in the field, along with separate side tracks to provide workshops geared toward personalized learning in smaller and more intimate settings. With 3 tracks – medical oncology, surgical and radiation oncology, and case-based SOGO Seminars — the program is designed to match the learning interests of everyone who attends.

Agenda Highlights

• Treating Young Patients With Colon Cancer
• GE-Junction Tumors: Esophageal or Gastric, Does It Matter?
• DEBATE: Has the Sun Set on Radiation Therapy for Locally Resectable, Early Stage PDAC?
•  Treating Early Stage Rectal Cancer After Complete Response Following Preoperative Chemoradiotherapy: Watch and Wait, or Resect?
• Medical Crossfire®: Evolution of Rectal Cancer
• PRRT: When and How
• Medical Crossfire: Role of Circulating Tumor DNA (ctDNA) in Monitoring Gastrointestinal Malignancies

5th Annual School of Gastrointestinal Oncology™ (SOGO®)
Saturday, March 21, 2020
MGM National Harbor®
101 MGM National Avenue
Oxon Hill, MD

gotoper.com/go/SOGO20SD

Program Co-Chairs

Accreditation/Credit Designation
Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC, designates this live activity for a maximum of 7.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians' Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669, for 7.25 Contact Hours.

Oncology is changing. The future will be more precise.

InterContinental® New York Barclay | April 17-18, 2020

 At this pan-tumor, interactive symposium, discussions will encompass the latest topics in major solid and liquid tumors. This symposium will cover key malignancies, including lung cancers, breast cancers, gastrointestinal cancers, genitourinary cancers, skin cancers, and hematologic malignancies, and feature keynote lectures focusing on precision medicine.

Agenda Highlights

• Genomics of Response to Immune Checkpoint Therapies for Cancer: Implications for Precision Medicine
• Novel Targets and Precision Medicine for Prostate Cancer    
• DLBCL: How Do Modern Diagnostics Identify High-Risk Diffuse Large B-Cell Lymphoma Subsets and Alter Treatment
• Follicular Lymphoma in 2020: Picking and Rationalizing First-Line Therapy    
• MM: How the MMRF Cohort Can Teach Us the Best Sequence of Therapy
• Predicting Toxicity and Efficacy of CAR T cells
• Genomic Approaches to Immunological Signatures and Their Implications

Program Chair

Andre H. Goy, MD
Professor of Medicine
Georgetown University
Chairman and Executive Director
Chief, Division of Lymphoma
Director, Clinical and Translational Research
John Theurer Cancer Center at UMC
Chief Science Officer
Regional Care Associates
Lydia Pfund Chair for Lymphoma
Seton Hall-Hackensack Meridian School of Medicine
Hackensack, NJ

Benefits of Attending

• Network with your peers and the top minds in precision medicine.
• Learn to better understand genomic approaches to immunological signatures and their implications.
• Update your knowledge of tumor-agnostic clinical studies.
• Implement precision medicine into lung, breast, GI, GU & skin cancer, plus hematologic malignancies.

2nd Annual Precision Medicine Symposium
April 17-18, 2020
InterContinental® New York Barclay
111 E 48th Street, New York, NY 10017
gotoper.com/go/PMC20SD

*Discount only valid for healthcare professionals. Restrictions may apply.

Accreditation/Credit Designation
Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
This activity has been approved for AMA PRA Category 1 Credit™.Physicians' Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669.
The program content has been reviewed by the Oncology Nursing Certification Corporation (ONCC) and is acceptable for recertification points.

November 5-7, 2020
Emory Conference Center Hotel | Atlanta, GA

Accreditation/Credit Designation
Physicians (CME)
Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Physicians' Education Resource®, LLC designates this live activity for a maximum of 27.25 AMA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses (Contact Hours)
Physicians' Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669 for 27.25 Contact Hours.
Maintenance of Certification (MOC) Points
Medical Oncologists (ABIM)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 27.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Surgical Oncologists/Surgeons
This activity provides Category I CME and self-assessment credits toward Part 2 of the ABS MOC Program. For more information, please visit www.absurgery.org

Join Us Tonight! - March 23, 2020
8:00 PM  EST

The novel coronavirus that causes COVID-19 infection is rapidly becoming one of the most challenging public health crises in modern history. With more than 200,000 confirmed infections worldwide, including more than 4000 cases in the United States, this virus has the potential to infect individuals of all ages. However, older individuals and patients with underlying health conditions, including cardiovascular disease, diabetes, and pulmonary disorders, seem to be most vulnerable to infection and to developing more severe illness. Patients with cancer must also be considered in this vulnerable and high-risk population.

But how is this pandemic specifically affecting cancer care, and what should you need to know to ensure you are providing the best care to your patients with cancer?

Participate in this live webcast and join the discussion on this fast-moving topic!

Learning Objectives

• Discuss the risk of infection with the novel coronavirus (SARS-CoV-2) and severity of illness with COVID-19 across the populations of patients with hematologic and solid tumor malignancies
• Identify optimal protocols for cancer facilities, in both the inpatient and outpatient settings, to help minimize the risk of coronavirus infection
• Assess strategies to optimize treatment protocols for patients with cancer in light of the current COVID-19 pandemic

Program Co-Chairs

Accreditation/Credit Designation
Physicians'' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians'' Education Resource®, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians'' Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.0 Contact Hour.

Acknowledgment of Commercial Support
This activity has been developed and funded by Physicians’ Education Resource®, LLC.

Ask  Oncology Experts Your
Critical  Questions about COVID-19''s
Impact on Patient Care

Monday, May 18, 2020
8 PM EDT

COVID-19 has become one of the most challenging health crises in modern history. With over 4 million cases confirmed worldwide, including over 1 million cases in the US (as of May 12, 2020), this virus has the potential to infect people of all ages.  

COVID-19 can cause a range of breathing problems, from mild to critical. Older adults and people who have other health conditions like heart disease, cancer, and diabetes may have more serious symptoms.

The COVID-19 outbreak has significantly changed how patient care is being administered. Face-to-face appointments are essential and telemedicine has become the new normal. There are new best practices to get used to in this new medical landscape, causing many advanced practitioners to learn new ways to communicate with patients.

Join us this Monday to learn from oncology experts who have been making progressive changes to  successfully administer care.

Extraordinary times call for extraordinary caregivers!

"This series breaks down best practices for cancer care during the pandemic, and prepares me for what''s to come." - Week 8 Viewer

Program Faculty

Accreditation/Credit Designation

Physicians'' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians'' Education Resource®, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians'' Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.0 Contact Hour.

Acknowledgment of Support
This activity is supported by educational grants from Bristol-Myers Squibb; Daiichi Sankyo, Inc.; Novartis Pharmaceuticals Corporation; and Pfizer Inc.

Thursday, March 19, 2020
8:00 PM – 9:30 PM EST

This live video webcast will explore current trends in prognostic scoring, molecular diagnostics, and guideline-based management of myeloproliferative neoplasms (MPNs). Learn about the  most appropriate treatments based upon patient and tumor characteristics, and hear the experts apply novel management strategies to real-world scenarios. The interactive forum will allow you to ask specific questions to optimize treatment strategies and manage adverse events for your patients.

Agenda Hot Topics

• The progressing utility of interferons
• High-risk mutations and their impact for treatment decision making
• Novel JAK inhibitors on the horizon
• Double and triple therapy combinations in clinical development

Program Chair

Accreditation/Credit Designation
Physicians'' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians'' Education Resource®, LLC, designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.5 Contact Hours.

Acknowledgment of Commercial Support
This activity is supported by educational grants from Celgene Corporation; Incyte Corporation; and PharmaEssentia USA.

Thursday, March 19, 2020
8:00 PM – 9:30 PM EST

This live video webcast will explore current trends in prognostic scoring, molecular diagnostics, and guideline-based management of myeloproliferative neoplasms (MPNs). Learn about the  most appropriate treatments based upon patient and tumor characteristics, and hear the experts apply novel management strategies to real-world scenarios. The interactive forum will allow you to ask specific questions to optimize treatment strategies and manage adverse events for your patients.

Agenda Hot Topics

• The progressing utility of interferons
• High-risk mutations and their impact for treatment decision making
• Novel JAK inhibitors on the horizon
• Double and triple therapy combinations in clinical development

Program Chair

Accreditation/Credit Designation
Physicians'' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians'' Education Resource®, LLC, designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.5 Contact Hours.

Acknowledgment of Commercial Support
This activity is supported by educational grants from Celgene Corporation; Incyte Corporation; and PharmaEssentia USA.

Beat the heat this summer with virtual CME/CE from PER®

During this time of transition, the summer meetings may look different, but PER®’s commitment to world-class CME/CE remains the same. Our proven live-stream platform will deliver all of the legacy conferences you and your colleagues have turned to for more than 20 years — with a few new additions to meet the evolving needs of the PER® community. You can be assured that each event will deliver the same level of impactful education and unrivaled faculty access as ever.

Learn more about our upcoming events for July, and register online today.

July 2020

Complimentary live webcasts on the latest updates from the Annual Oncology Meeting at convenient dates and times. Join industry experts as they discuss recent advancements in oncology care. 

Monday, July 8

This webcast is part of a regularly occurring series, held each Monday at 8 PM EDT, which features new experts each week. How is this pandemic specifically affecting cancer care, and what do clinicians need to know today to ensure they are providing the best care to their patients with cancer?

Tuesday, July 7

During this Medical Crossfire®, expert faculty specializing in pulmonology, rheumatology, and diagnostic radiology will share multidisciplinary perspectives and opposing views on making an accurate diagnosis and considering treatment with antifibrotics that can delay disease progression. As part of this webcast, faculty will review ILDs with progressive fibrosing phenotypes with their unique patterns of fibrosis, and will also discuss the role and risks of advanced diagnostic procedures.

Tuesday, July 7

Medical Crossfire®: Perfecting the Diagnosis and Treatment of EGPA: Patient Perspectives and Expert Insights will highlight current unmet medical needs and the most recent advances in the management of eosinophilic granulomatosis with polyangiitis (EGPA). This program has been transformed into an interactive webcast which features a panel discussion of expert faculty specializing in the care of patients diagnosed with EGPA.

Tuesday, June 16

This live webcast will be presented by experts in NSCLC to discuss testing strategies for HER2 alterations in a clinically applicable manner. The expert panel will discuss current and emerging treatment options for HER2 alteration-positive NSCLC.

Saturday, July 11

PER®, presents the 4th Annual Live Medical Crossfire®: Hematologic Malignancies—a 1-day, highly engaging conference designed to explore the most pressing clinical issues in the field of hematologic malignancies through live, interactive panel discussions with renowned experts. This live-stream meeting will contrast viewpoints of key thought leaders from across the country and the world regarding current standards of practice and emerging clinical data for liquid tumors.

Wednesday, July 15

This live webcast will be presented by experts in SCLC and will begin with a rapid overview of clinical data leading to recent approvals, as well as emerging approaches and management of treatment-related adverse events. The heart of this program includes several case-based tumor board discussions addressing the application of new agents in a variety of clinical settings in SCLC.

EAST: Friday-Saturday, July 17-18
WEST: Friday-Saturday, July 31- August 1

The 19th Annual International Congress on the Future of Breast Cancer® will update clinicians on recent advances in the treatment of breast cancer, from breakthroughs in the lab to changes in treatment paradigms. Join Program Chair Joyce A. O’Shaughnessy, MD, and Sara Hurvitz, MD, and other faculty as they share practical implications of emerging data for patient care in the clinic. This virtual conference provides a unique opportunity for medical, surgical, and radiation oncologists to increase knowledge, apply new data to practice, and, ultimately, improve patient care.

July 23-25

The 21st Annual International Lung Cancer Congress® will provide current, practical information on the management of lung cancer, as well as a look at the novel agents and strategies that may potentially shape the future of lung cancer therapy. Throughout this interactive virtual conference, leading international and national experts will provide perspectives on how to apply the latest data on targeted agents, immunotherapy, surgery, and radiation oncology in the clinic.

July 31 - August 1

Rapid advancements in the field of oncology nursing are raising the bar for the care of your patients, and the 4th Annual School of Nursing Oncology™ is an ideal setting to learn about the latest updates in a practical and applicable way. Join us for this 2-day virtual conference to explore the numerous advancements in the pharmacologic treatment of cancer, as well as complementary therapies to help mitigate disease symptoms and potential treatment-related adverse events that are emerging at a rapid pace.

Saturday, March 21, 2020
MGM National Harbor® | Oxon Hill, MD

Use code SOGO20SD at checkout by to save 35%

Led by world-renowned experts John L. Marshall, MD, and Michael A. Choti, MD, MBA, FACS, this multitrack symposium, now in its fifth year, will provide attendees with the tools needed to personalize care for each one of their patients with gastrointestinal (GI) cancer. The program will include various modules that feature general presentations on important concepts in the field, along with separate side tracks to provide workshops geared toward personalized learning in smaller and more intimate settings. With 3 tracks – medical oncology, surgical and radiation oncology, and case-based SOGO Seminars — the program is designed to match the learning interests of everyone who attends.

Agenda Highlights

• Treating Young Patients With Colon Cancer
• GE-Junction Tumors: Esophageal or Gastric, Does It Matter?
• DEBATE: Has the Sun Set on Radiation Therapy for Locally Resectable, Early Stage PDAC?
•  Treating Early Stage Rectal Cancer After Complete Response Following Preoperative Chemoradiotherapy: Watch and Wait, or Resect?
• Medical Crossfire®: Evolution of Rectal Cancer
• PRRT: When and How
• Medical Crossfire: Role of Circulating Tumor DNA (ctDNA) in Monitoring Gastrointestinal Malignancies

5th Annual School of Gastrointestinal Oncology™ (SOGO®)
Saturday, March 21, 2020
MGM National Harbor®
101 MGM National Avenue
Oxon Hill, MD

gotoper.com/go/SOGO20SD

Program Co-Chairs

Accreditation/Credit Designation
Physicians'' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this live activity for a maximum of 7.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians'' Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669, for 7.25 Contact Hours.

Acknowledgment of Commercial Support
This activity is supported by educational grants from AstraZeneca; Daiichi Sankyo, Inc.; Genentech, Inc.; and Taiho Oncology, Inc.

Join Us Tonight! - March 23, 2020
8:00 PM  EST

The novel coronavirus that causes COVID-19 infection is rapidly becoming one of the most challenging public health crises in modern history. With more than 200,000 confirmed infections worldwide, including more than 4000 cases in the United States, this virus has the potential to infect individuals of all ages. However, older individuals and patients with underlying health conditions, including cardiovascular disease, diabetes, and pulmonary disorders, seem to be most vulnerable to infection and to developing more severe illness. Patients with cancer must also be considered in this vulnerable and high-risk population.

But how is this pandemic specifically affecting cancer care, and what should you need to know to ensure you are providing the best care to your patients with cancer?

Participate in this live webcast and join the discussion on this fast-moving topic!

Learning Objectives

• Discuss the risk of infection with the novel coronavirus (SARS-CoV-2) and severity of illness with COVID-19 across the populations of patients with hematologic and solid tumor malignancies
• Identify optimal protocols for cancer facilities, in both the inpatient and outpatient settings, to help minimize the risk of coronavirus infection
• Assess strategies to optimize treatment protocols for patients with cancer in light of the current COVID-19 pandemic

Program Co-Chairs

Accreditation/Credit Designation
Physicians'' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians'' Education Resource®, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians'' Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.0 Contact Hour.

Acknowledgment of Commercial Support
This activity has been developed and funded by Physicians’ Education Resource®, LLC.

Join PER® for a high-impact,
all-virtual year of
CME conferences

WEBCAST HAS BEEN RESCHEDULED
New Date: Wednesday, May 20, 2020
8:00 PM – 9:30 PM EST

Because of travel bans affecting the faculty''s journey to our studio, we have made the decision to move the date of the live webcast from this Thursday to May 20th, 2020. We hope that you are still able to join us. Your registration will not be affected by this change of date. Please stay tuned for any further updates.

This live video webcast will explore current trends in prognostic scoring, molecular diagnostics, and guideline-based management of myeloproliferative neoplasms (MPNs). Learn about the  most appropriate treatments based upon patient and tumor characteristics, and hear the experts apply novel management strategies to real-world scenarios. The interactive forum will allow you to ask specific questions to optimize treatment strategies and manage adverse events for your patients.

Agenda Hot Topics

• The progressing utility of interferons
• High-risk mutations and their impact for treatment decision making
• Novel JAK inhibitors on the horizon
• Double and triple therapy combinations in clinical development

Program Chair

Accreditation/Credit Designation
Physicians'' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians'' Education Resource®, LLC, designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.5 Contact Hours.

Acknowledgment of Commercial Support
This activity is supported by educational grants from Celgene Corporation; Incyte Corporation; and PharmaEssentia USA.

Monday, March 23, 2020
8:00 PM  EST